Flow Cytometry Market Size Projected to Rise Lucratively by 2027: Grand View Research Inc.

 

Flow Cytometry Market Growth & Trends

The global flow cytometry market size is expected to reach a value of USD 11.5 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2021 to 2027. The high prevalence of chronic diseases, the introduction of technologically advanced flow cytometry solutions, and increasing R&D investments in the pharmaceutical industry are expected to propel market growth over the forecast period.

Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. Also, in January 2019, Beckman Coulter, a subsidiary of Danaher Corporation, expanded its clinical flow cytometry portfolio with the launch of its new ClearLLab 10C System. This newly launched integrated solution provides a standardized workflow that offers reliability and consistent clinical findings.

Technological advancements, resulting in enhanced accuracy, portability, and cost-effectiveness, are expected to present this market with future growth opportunities. Small-sized high-throughput cytometers are anticipated to gain popularity in the near future due to their associated benefits, such as ease of use and cost-effectiveness. Furthermore, improvements in fluorescent dyes and the introduction of bench-top cytometers are factors expected to drive market growth. Rapid advancements in multicolor flow cytometry, which has extensive applications in new drug development, have led to an easy cellular analysis by simultaneous evaluation of several parameters. These devices are extensively adopted by many contract research organizations.

Furthermore, the increasing prevalence of cancer, immunodeficiency disorders, and infectious diseases, including the outbreak of COVID-19, has significantly driven the demand for flow cytometry solutions for research and clinical applications. As per the American Cancer Society estimates, in 2020, around 1.8 million new cancer cases will be diagnosed in the U.S. Also, according to the data published by the National Cancer Institute (NCI), as of January 2019, there were around 16.9 million cancer survivors in the U.S.

Request a free sample copy or view report summary: Flow Cytometry Market Report

Flow Cytometry Market Report Highlights

• Instruments accounted for the largest market share in 2020, owing to its high demand for commercial and clinical applications
• The software segment is expected to register the fastest growth owing to new product developments in this field
• The research segment is anticipated to witness lucrative CAGR over the forecast period owing to increasing R&D activities pertaining to cancer and infectious diseases
• The outbreak of COVID-19 has drastically upsurged the demand for advanced flow cytometry solutions for research purposes
• North America dominated the market and accounted for the largest revenue share in 2020. Well-established healthcare infrastructure and the presence of an established pharmaceutical industry are facilitating the dominance of this region during the study period
• The Asia Pacific region is expected to witness significant growth owing to the increasing demand for flow cytometry solutions in emerging economies such as China and India

Access Press Release@ https://www.grandviewresearch.com/press-release/global-flow-cytometry-market

Flow Cytometry Market Segmentation

Grand View Research has segmented the global flow cytometry market on the basis of product, technology, application, end-use, and region:

Flow Cytometry Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
  • Cell Analyzers
  • Cell Sorters
• Reagents & Consumables
• Software
• Accessories
• Services

Flow Cytometry Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Cell-based
• Bead-based

Flow Cytometry Application Outlook (Revenue, USD Million, 2016 - 2027)

• Research
  • Pharmaceutical
    • Drug Discovery
    • Stem Cell
    • In Vitro Toxicity
  • Apoptosis
  • Cell Sorting
  • Cell Cycle Analysis
  • Immunology
  • Cell Viability
• Industrial
• Clinical
  • Cancer
  • Organ Transplantation
  • Immunodeficiency
  • Hematology

Flow Cytometry End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Commercial Organizations
• Hospitals
• Academic Institutes
• Clinical Testing Labs

Flow Cytometry Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Flow Cytometry Market

• Danaher Corporation
• Becton, Dickinson and Company
• Luminex Corporation
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec
• Sysmex Corporation
• Stratedigm, Inc.
• Apogee Flow Systems Ltd.
• Sony Biotechnology, Inc.
• Thermo Fisher Scientific, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Histology & Cytology Market to Rear Excessive Growth CAGR of 13.1% from 2021 to 2028: Grand View Research Inc.

 

Histology And Cytology Market Growth & Trends

The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.1% from 2021 to 2028. The factors contributing to market growth include increasing incidence of cancer, development of advanced tools for early disease diagnosis, implementation of immunohistochemistry, and innovation in microscopy.

In addition, organizations are collaborating for the standardization of cytopathology across the world, which is driving the market. For instance, in May 2020, International Agency for Research on Cancer (IARC) entered in collaboration with The International Academy of Cytology (IAC) for publishing a series of cytopathology reporting systems, for presenting an international approach that can be used for cytopathology of different body sites. The two organizations are engaged in the expansion and development of internationally recognized diagnostic reports for cancer and other precancerous disorders worldwide.

Moreover, companies are launching new and automated instruments for cytology which can be further attributed to the market growth. For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge. It helps in the automation of the staining and preparation of specimens that are used in liquid-based cytology for facilitating the investigation of a collection of cell differentiation by using Papanicolaou staining techniques.

COVID-19 has become a catalyst for changing traditional pathology workflows with the integration of Artificial Intelligence (AI) and digitalization solutions. During the pandemic, these tools have helped and continue to assist in remote reviewing of pathological cases hence preventing delay in patient care. Companies have reported the increasing adoption of digital pathology solutions post COVID-19.

Request a free sample copy or view report summary: Histology And Cytology Market Report

Histology And Cytology Market Report Highlights

• The cytology segment accounted for the largest revenue share in 2020 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology system
• The histology is expected to witness gradual growth from 2021 to 2028 owing to moderate innovation in histological systems
• The consumables and reagents segment dominated the market, attributed to the expanding portfolios of the entities operating in the consumable market space
• The instruments and analysis software system segment is expected to witness a substantial CAGR from 2021 to 2028, attributed to the steep increase in the demand for automated histology instruments
• The cervical cancer segment represented the majority of the market in 2020 owing to the increasing application of the Pap test in the early diagnosis of cervical cancer
• Institutes are integrating computer algorithm for improving the accuracy and efficiency of cervical cancer screening
• For instance, in June 2020, an NIH study integrated a computer algorithm with cytology (Pap test) for increasing the efficiency of cervical cancer screening. The new approach involves an AI platform for dual-stain evaluation
• The other cancers segment is expected to witness a lucrative growth rate of 18.0% owing to increasing diagnosis of various cancers such as pancreatic cancer and bladder cancer with histopathology and cytopathology
• The drug discovery and designing segment accounted for the highest revenue share in 2020 owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
• North America accounted for the highest revenue share in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-histology-cytology-market

Histology And Cytology Market Segmentation

Grand View Research has segmented the global histology and cytology market on the basis of type of examination, product, application, and region:

Histology & Cytology Type Of Examination Outlook (Revenue, USD Million, 2017 - 2028) 

• Histology
  • By Technique
    • Microscopy
    • Immunohistochemistry
    • Molecular pathology
    • Cryostat & Microtomy
  • Cytology
    • By Technique
      • Microscopy
      • Immunohistochemistry
      • Molecular pathology
      • Cryostat & Microtomy
    • By Application
      • Breast Cancer
      • Cervical Cancer
      • Bladder Cancer
      • Lung Cancer
      • Other Cancers

Histology & Cytology Product Outlook (Revenue, USD Million, 2017 - 2028)

• Instruments and Analysis Software System
• Consumable and Reagents

Histology & Cytology Application Outlook (Revenue, USD Million, 2017 - 2028)

• Drug Discovery & Designing
• Clinical Diagnostics
• Research

Histology & Cytology Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Histology And Cytology Market

• Hologic, Inc.
• Hoffmann-La Roche Ltd.
• Abbott
• Becton, Dickinson and Company
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation
• Trivitron Healthcare
• Koninklijke Philips N.V.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Active Pharmaceutical Ingredient Market is Expected to Enhance $312.56 Billion Revenue By 2028: Grand View Research Inc.

 

Active Pharmaceutical Ingredient Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Request a free sample copy or view report summary: Active Pharmaceutical Ingredient Market Report

Active Pharmaceutical Ingredient Market Report Highlights

• According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
• The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
• According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
• Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
• Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market

Active Pharmaceutical Ingredient Market Segmentation

Grand View Research has segmented the global active pharmaceutical ingredients market based on type of synthesis, type of manufacturer, type, application, and region:

Active Pharmaceutical Ingredient Type of Synthesis Outlook (Revenue, USD Billion, 2017 - 2028)

• Biotech
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
• Synthetic

Active Pharmaceutical Ingredient Type of Manufacturer Outlook (Revenue, USD Billion, 2017 - 2028)

• Captive APIs
• Merchant APIs

Active Pharmaceutical Ingredient Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Generic APIs
• Innovative APIs

Active Pharmaceutical Ingredient Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Cardiovascular Diseases
• Oncology
• CNS and Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

Active Pharmaceutical Ingredient Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Active Pharmaceutical Ingredient Market

• Merck & Co., Inc.
• AbbVie, Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Teva Pharmaceutical Industries Ltd.
• Albemarle Corporation
• Viatris Inc.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Reddy’s Laboratories Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmacy Automation Devices Market is Anticipated to Upgrade $9.5 Billion Revenue By 2028: Grand View Research Inc.

 

Pharmacy Automation Devices Market Growth & Trends

The global pharmacy automation devices market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The increasing burden of chronic diseases and the growing geriatric population are leading to an increase in the number of prescriptions. This, in turn, is resulting in a rise in the number of medication errors. For instance, 237.4 million medication errors occurred in England in 2018, according to the article published in The Pharmaceutical Journal. This is driving the demand for pharmacy automation devices. Moreover, an increase in initiatives by various organizations, such as the American Society of Health-System Pharmacists, to reduce medication errors is positively impacting the market growth.

In 2020, the medication dispensing systems product segment accounted for the largest revenue share owing to the benefits offered by these products, such as minimized medication errors, better inventory management, improved medication adherence for patients with complex treatments, improved patient care, minimized drug waste with true split-fills, improved storage capacity, and reduced administrative burden among the end-users. The automated medication compounding systems segment is anticipated to witness the fastest growth during the forecast period. Reduction in compounding errors and contamination is a major factor driving the segment. Moreover, the increasing adoption of these devices for sterile compounding is fueling the segment growth.

The retail pharmacy end-use segment accounted for the largest revenue share in 2020. The rising adoption of these solutions, the presence of a large number of retail pharmacies, and growing investments in this sector are driving the segment. For instance, in May 2018, McKesson Co., a Healthcare Information Technology (HIT) company, entered into an agreement with Discount Drug Mart, which is an Ohio-based retail drug store, to build an automated central fill pharmacy. The hospital pharmacy is anticipated to witness the fastest growth during the forecast period owing to the adoption of automated technologies by hospitals. For instance, in February 2020, Geisinger, a health provider in the U.S., partnered with Omnicell, Inc. for the implementation of an automated dispensing system.

In 2020, North America dominated the market. This is attributed to the presence of a large number of industry players, such as BD, Omnicell, Baxter, AmerisourceBergen, and Cerner. The majority of the companies such as BD and Baxter generated more than 50% of sales revenue in the U.S. Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rapid adoption in automated solutions, investments in the adoption of healthcare IT infrastructure, and high healthcare spending are the key factors contributing to the growth of the market. Moreover, initiatives by public and private bodies to reduce medication errors are likely to drive the regional market.

Request a free sample copy or view report summary: Pharmacy Automation Devices Market Report

Pharmacy Automation Devices Market Report Highlights

• The market is driven by various technological advancements and increasing investments in the automation sector
• Based on product, the medication dispensing systems segment dominated the market in 2020 owing to the increasing adoption of these products to avoid errors while dispensing medication
• By end-use, the retail pharmacy segment dominated the market in 2020 owing to high adoption rates of these devices and investments by major retail chains, such as CVS Health and Walgreens
• North America dominated the market in 2020 owing to the presence of a large number of automation companies in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmacy-automation-market

Pharmacy Automation Devices Market Segmentation

Grand View Research, Inc. has segmented the global pharmacy automation devices market on the basis of product, end-use, and region:

Pharmacy Automation Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Medication Dispensing Systems
• Packaging and Labeling Systems
• Storage and Retrieval Systems
• Automated Medication Compounding Systems
• Tabletop Tablet Counters

Pharmacy Automation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Pharmacy
• Retail Pharmacy

Pharmacy Automation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Pharmacy Automation Devices Market

• Amerisource Bergen Corporation
• Accu Chart Plus Healthcare Systems, Inc.
• Omnicell, Inc.
• McKesson Corporation
• Pearson Medical Technologies, LLC
• Baxter
• Talyst, LLC
• ScriptPro, LLC
• CareFusion (Becton Dickinson And Company)
• Medacist Solutions Group, LLC
• Kirby Lester
• Cerner Corporation
• iA
• ARxIUM
• TouchPoint Medical
• Deenova S.R.L
• Parata Systems, LLC
• Swisslog Healthcare
• Yuyama Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hemoglobinopathies Market Valuation to Reach $15.7 Billion by the end of 2028

 

Hemoglobinopathies Market Growth & Trends

The global hemoglobinopathies market size is expected to reach USD 15.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.8% from 2021 to 2028. Increasing awareness regarding hemoglobinopathies and government initiatives to diagnose the diseases at an early stage are expected to propel the market growth over the forecast period. Moreover, increasing R&D investment, the presence of a promising drug pipeline, and technologically advanced diagnostics platforms are expected to boost the growth of the market.

The development of novel curative technologies, such as CRISPR/Cas9 and hematopoietic stem cell transplantation, coupled with a promising pipeline, is expected to propel market growth. Moreover, the presence of regulatory agencies, such as the FDA, which are working toward improving drug approval rate by granting accelerated approval for hemoglobinopathies drugs, is expected to drive the market. For instance, in 2019, the FDA has approved four novel drugs: Reblozyl by Bristol-Myers Squibb Company, Adakveo by Novartis AG, Zynteglo by bluebird bio, Inc., and Oxbryta by Global Blood Therapeutics, Inc. for the treatment of hemoglobinopathies.

Initiatives such as the Sickle Cell Awareness Initiative (SCAI) are working toward educating the people about the disease, which will increase the diagnosis and treatment rate. SCAI also raises funds for individuals affected with sickle cell diseases (SCDs) and provides research funding. Moreover, governments of Middle Eastern and Asian countries provide funds for R&D of hemoglobinopathies treatment. For instance, various programs undertaken by governments, such as thalassemia screening in neonates and providing medicines, are impacting the market growth positively.

The high patient population in low-income countries has encouraged market players and non-profit organizations to launch several initiatives to improve the access to the therapy. For instance, in February 2019, the Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) was launched by Global Blood Therapeutics, Inc. in order to provide research funding for novel SCD projects, with an aim to expand the access to optimal healthcare for sickle cell disease.

Biopharmaceutical companies are collaborating with nonprofit organizations to promote public awareness about hemoglobinopathies. For instance, in June 2018, the Sickle Cell Disease Association of America partnered with Emmaus Life Sciences, Inc. to provide online educational tools to sickle cell patients, friends, clinicians, caregivers, and researchers for spreading awareness about complications associated with SCD.

An increase in investment and funding for the development of novel therapies to treat hemoglobinopathies will further boost the market growth over the forecast period. The National Heart, Lung, and Blood Institute (NHLBI) has significantly invested in research & development in sickle cell disease. The NHLBI supports research work through various initiatives. Furthermore, private funding such as the Bronx Blood Research Fund (BBRF) provides a platform for research and management of thalassemia and other hemoglobinopathies.

Gene therapy has emerged as a promising treatment option for managing hemoglobin disorder as it targets the underlying genetic cause of the condition through the administration of one-time gene therapy and significantly reduces the need for blood transfusions. The current pipeline of gene therapy products includes CTX001 (CRISPR Therapeutics), BIVV003 (Sangamo Therapeutics, Inc. & Bioverativ Inc), and HGB-206 (bluebird bio, Inc).

Request a free sample copy or view report summary: Hemoglobinopathies Market Report

Hemoglobinopathies Market Report Highlights

• Based on type, sickle cell disease accounted for the largest share of 56.6% in 2020 and is anticipated to maintain its lead over the forecast period
• The newborn patient population with sickle cell anemia is anticipated to reach 400,000 by 2050. Half of the global sickle cell anemia burden is present in India, Nigeria, and the Democratic Republic of the Congo
• By therapy, in the thalassemia segment, the blood transfusion segment held the largest market share in 2020 and is estimated to dominate the market throughout the forecast period
• Asia Pacific is expected to witness the fastest growth over the forecast period owing to a large potential patient base and high unmet medical needs in the region
• North America held the largest market share in 2020 due to government initiatives focusing on the development of new therapies and better reimbursement scenario

Access Press Release@ https://www.grandviewresearch.com/press-release/global-hemoglobinopathies-market

Hemoglobinopathies Market Segmentation

Grand View Research has segmented the global hemoglobinopathies market on the basis of type, diagnosis, therapy, and region:

Hemoglobinopathies Type Outlook (Revenue, USD Million, 2017 - 2028)

• Thalassemia
• Sickle Cell Disease
• Other Hemoglobin (Hb) Variants

Hemoglobinopathies Diagnosis Outlook (Revenue, USD Million, 2017 - 2028)

• Thalassemia
  • Blood Test
  • Genetic Test
  • Prenatal Genetic Test
  • Pre-implantation Genetic Diagnosis
  • Electrophoresis
  • Others
• Sickle Cell Disease
  • Blood Test
  • Genetic Test
  • Prenatal Genetic Test
  • Electrophoresis
  • Others
• Other Hemoglobin (Hb) Variants
  • Blood Test
  • Genetic Test
  • Prenatal Genetic Test
  • Electrophoresis
  • Others

Hemoglobinopathies Therapy Outlook (Revenue, USD Million, 2017 - 2028)

• Thalassemia
  • Blood Transfusion
  • Iron Chelation Therapy
  • Bone Marrow Transplant
  • Others
• Sickle Cell Disease
  • Blood Transfusion
  • Hydroxyurea
  • Bone Marrow Transplant
  • Others
• Other Hemoglobin (Hb) Variants
  • Blood Transfusion
  • Hydroxyurea
  • Iron Chelation Therapy
  • Bone Marrow Transplant
  • Others

Hemoglobinopathies Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • India
  • China
  • Japan
  • Singapore
  • Australia
  • South Korea
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa

List of Key Players of Hemoglobinopathies Market

• Sangamo Therapeutics, Inc.
• Global Blood Therapeutics, Inc.
• bluebird bio, Inc.
• Emmaus Life Sciences Inc.
• Pfizer, Inc.
• Novartis AG
• Prolong Pharmaceuticals, LLC
• Bioverativ Inc.
• Gamida Cell

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cold Chain Market Share Worth Over $628.26 Billion by 2028

 

Cold Chain Market Growth & Trends

The global cold chain market size is estimated to reach USD 628.26 billion by 2028, according to a new study by Grand View Research, Inc., registering a CAGR of 14.8% from 2021 to 2028. Technological advancements in the packaging, processing, and storage of seafood products are expected to drive the market over the forecast period. Cold chain solutions have become an integral part of Supply Chain Management (SCM) for the transportation and storage of temperature-sensitive products. Increasing trade of perishable products is anticipated to drive product demand over the forecast period.

Companies operating in this market are increasingly adopting alternative energy solutions, such as wind and solar energy, to minimize the overall operating costs. Among cold chain solutions, the refrigeration system is used to maintain the quality of products and enhance their shelf life. However, refrigerants used in refrigeration systems pose a threat to the environment because of their high Global Warming Potential (GWP) and Ozone Depletion Potential (ODP). Stringent food safety regulations, such as the Food Safety Modernization Act that requires increased attention toward the construction of cold storage warehouses, are slated to benefit the market.

Adoption of environmental audit systems, such as Leadership in Energy and Environmental Design (LEED) or Building Research Establishment Environmental Assessment Method (BREEAM), can evaluate designs at an initial stage. Thus, the operational performance of completed buildings can be assessed through these audit systems. Temperature-controlled warehouses are highly energy-sensitive as they incorporate refrigeration and ventilation systems that require high power consumption. However, better designs can reduce power consumption and can help build net-zero energy warehouses.

Intelligent warehouse automation and control systems are one of the factors assisting buildings to achieve net-zero energy to become self-sustainable. Less energy consumption notably lowers operating expenditure, eventually contributing to the protection of ecology and climate. In terms of revenue, North America is anticipated to be the largest regional market by 2028. Mexico is expected to have exponential growth over the forecast period owing to the rising investments for the development of logistics infrastructure and increasing penetration of the Warehouse Management System (WMS).

In South America, Brazil is a major contributor to market growth. Implementation of dietary guidelines on the usage of fresh food products over processed food led by the Brazilian government is expected to boost the market in the country. These guidelines require the development of cold chains to meet the requirements for storage, transportation, and packaging of fresh food. Many service providers have invested in adding onboard tracking equipment to refrigeration units. This provides real-time location and temperature data to shippers and third-party logistics. It further helps them with increased visibility and opportunity to mitigate or prevent losses.

Request a free sample copy or view report summary: Cold Chain Market Report

Cold Chain Market Report Highlights

• Due to a shift in focus from increasing productivity to providing better transport and storage facilities, the market has gained prominence in developing countries, such as China and India
• Cold chain monitoring, smart packaging, sample lifecycle management, men and material tracking, and connected equipment are among IoT applications of key importance for the pharmaceuticals industry
• Radio Frequency Identification (RFID)-enabled supply chain provides higher efficiency and has opened up new growth opportunities by offering product-level visibility
• Globalization and rising number of pharmaceutical and food safety counterfeit incidents have compelled governments to tighten regulations pertaining to production and supply
• The Government of India remains keen on supporting the development of the cold chain industry and is encouraging private participation by launching subsidy schemes and offering grants

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cold-chain-market

Cold Chain Market Segmentation

Grand View Research has segmented the global cold chain market on the basis of type, packaging, equipment, application, and region:

Cold Chain Type Outlook (Revenue, USD Million, 2017 - 2028)

• Storage
  • Warehouses
    • On-grid
    • Off-grid
  • Reefer Containers
• Transportation
  • Road
  • Sea
  • Rail
  • Air
• Monitoring Components
  • Hardware
    • Sensors
    • RFID Devices
    • Telematics
    • Networking Devices
  • Software
    • On-premise
    • Cloud-based

Cold Chain Packaging Outlook (Revenue, USD Million, 2017 - 2028)

• Product
  • Crates
    • Dairy
    • Pharmaceuticals
    • Fishery
    • Horticulture
  • Insulated Containers & Boxes
    • Payload Size
      • Large (32 to 66 liters)
      • Medium (21 to 29 liters)
      • Small (10 to 17 liters)
      • X-small (3 to 8 liters)
      • Petite (0.9 to 2.7 liters)
    • Type
      • Cold Chain Bags/Vaccine Bags
      • Corrugated Boxes
      • Others
    • Cold Packs
    • Labels
    • Temperature-controlled Pallet Shippers
  • Materials
    • Insulating Materials
      • EPS
      • PUR
      • VIP
      • Cryogenic Tanks
      • Others (Insulating Pouches, Hard Cased Thermal Boxes, and Active Thermal Systems)
    • Refrigerants
      • Fluorocarbons
        • Inorganics
        • Ammonia
      • CO2
      • Hydrocarbons

Cold Chain Equipment Outlook (Revenue, USD Million, 2017 - 2028)

• Storage Equipment
  • On-grid
    • Walk-in Coolers
    • Walk-in Freezers
    • Ice-lined Refrigerators
    • Deep Freezers
  • Off-grid
    • Solar Chillers
    • Milk Coolers
    • Solar-powered Cold Boxes
    • Others (Solar Refrigerators and Products related to Solar Panels)
  • Transportation Equipment

Cold Chain Application Outlook (Revenue, USD Million, 2017 - 2028)

• Fruits & Vegetables
• Fruit Pulp & Concentrates
• Dairy Products
  • Milk
  • Butter
  • Cheese
  • Ice cream
• Fish, Meat, and Seafood
• Processed Food
• Pharmaceuticals
  • Vaccines
  • Blood Banking
• Bakery & Confectionary
• Others (Ready-to-Cook, Poultry)

Cold Chain Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Asia Pacific
  • China
  • India
  • Japan
  • Singapore
  • South Korea
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• South America
  • Brazil
• Middle East
  • UAE
  • Saudi Arabia
  • Israel
• Africa
  • South Africa
  • Nigeria
  • Egypt
  • Kenya

List of Key Players of Cold Chain Market

• Agro Merchant Group (U.S.)
• Nordic Logistics and Warehousing, LLC (U.S.)
• Preferred Freezer Services, LLC (U.S.)
• Cold Chain Technologies, Inc. (U.S.)
• Cryopack Industries, Inc. (U.S.)
• Creopack (Canada)
• Cold Box Express, Inc. (U.S.)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Stem Cell Market Value Expected To Increase at a CAGR of 8.8% from 2021 to 2028: Grand View Research Inc.

 

Stem Cells Market Growth & Trends

The global stem cells market size is expected to reach USD 18.4 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.8% during the forecast period. The market is driven by the rising number of stem cell banks, growing focus on increasing therapeutic potential of these, and extensive research for the development of regenerative medicines, among other factors.

Companies are receiving robust funding for the development of cellular therapies for cancer, which is anticipated to supplement the market growth. For instance, in February 2021, Notch Therapeutics, Inc. received funding of USD 85 million for developing induced pluripotent therapies for cancer. The investment will support the development of the company’s iPSC-derived T cell-based therapeutic candidates and expanding the application of their proprietary Engineered Thymic Niche (ETN) platform.

The increasing focus on regenerative medicines is further driving the market growth. The iPSCs are gaining popularity for the development of personalized cellular therapies and are creating new opportunities for regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can help in the treatment of placenta complications during pregnancy.

The researchers discovered a new way for creating induced trophoblast stem cells which can be used for making placenta cells. The discovery will facilitate in developing a model human placenta in vitro and enabling a pathway for future cell therapies. The administration of cell therapy demonstrated positive results in the treatment of COVID-19 patients, which is further contributing to the market growth. In January 2020, a group of researchers used stem cell treatment on patients in Beijing, China for checking its effectiveness against COVID-19.

The patients received a single infusion of mesenchymal stem cells (MSCs) which was found to be effective in developing an immune response. However, to date, there are no MSCs that are approved by the U.S. Food and Drug Administration (FDA) for the treatment of COVID-19 owing to insufficient data on their role in treating COVID-19.

Request a free sample copy or view report summary: Stem Cells Market Report

Stem Cells Market Report Highlights

• ASCs segment accounted for the largest share of 85.7% in 2020 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin
• The iPSC segment is expected to witness a lucrative CAGR of 9.3% through 2021-2028 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company’s lead induced pluripotent stem cell (iPSC)-derived Cymerus
• Regenerative medicine dominated with a market share of 89.1% in 2020 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of $300,000 from MTPConnect’s Industry Growth Centre Project Fund for the development of regenerative medicines in the country
• Cell acquisition held the largest market share of 35.8% in 2020 and is expected to expand at the fastest CAGR through 2021-2028 owing to increasing research studies involving cell harvesting
• Allogenic therapy dominated with a market share of 58.2% in 2020 owing to the increasing application of allogeneic stem cell transplants for cancer treatment
• The North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players.
• Asia Pacific is expected to expand with the fastest CAGR of 9.0% through 2021 to 2028 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-stem-cells-market

Stem Cells Market Segmentation

Grand View Research has segmented the global stem cells market based on product, application, technology, therapy, and region:

Stem Cells Product Outlook (Revenue, USD Million, 2017 - 2028)

• Adult Stem Cells (ASCs)
  • Hematopoietic
  • Mesenchymal
  • Neural
  • Epithelial/Skin
  • Others
• Human Embryonic Stem Cells (HESCs)
• Induced Pluripotent Stem Cells (iPSCs)
• Very Small Embryonic Like Stem Cells

Stem Cells Application Outlook (Revenue, USD Million, 2017 - 2028)

• Regenerative Medicine
  • Neurology
  • Orthopedics
  • Oncology
  • Hematology
  • Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery and Development

Stem Cells Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion and Sub-Culture

Stem Cells Therapy Outlook (Revenue, USD Million, 2017 - 2028)

• Autologous
• Allogenic

Stem Cells Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Stem Cells Market

• CELGENE CORPORATION
• STEMCELL Technologies Inc.
• Lineage Cell Therapeutics, Inc.
• Osiris Therapeutics, Inc.
• Human Longevity, Inc.
• Cynata
• Cytori Therapeutics Inc.
• Advanced Cell Technology Inc.
• Promethera Biosciences
• Mesoblast Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand Medical Imaging Market Increasing in Most Part of World 2028

 Medical Imaging Market Growth & Trends

The global medical imaging market size is expected to reach USD 28.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. Increasing demand for advanced diagnostic systems in developing countries and growing trends of market player collaborations are some of the key factors driving the market.

Developing countries have shown a surge in the volume of imaging procedures in the past few years. The low density of installed imaging systems in these regions is expected to provide significant growth potential during the forecast period. Favorable government policies and booming medical tourism in these countries are expected to attract global market players in the untapped market.

The integration of multiple imaging modalities is expected to play an important role in market growth. These systems have accurate diagnostic capabilities and are available at affordable prices. The integration of imaging modalities with surgical suites is anticipated to open a new avenue for the market at the global level.

The development of portable diagnostic tools is important to expand the applications of imaging devices in ambulatory care, clinics, and emergency care departments. Handheld ultrasound devices provide quick and safer images that are critical in emergency care.

Ongoing trials and studies to explore the potential of MRI technology for the early detection of neurological conditions are showing positive results. The development of new radiofrequency coils is anticipated to expand these applications during the forecast period.

Request a free sample copy or view report summary: Medical Imaging Market Report

Medical Imaging Market Report Highlights

• By product, the ultrasound segment captured the largest share in 2020 and is expected to dominate throughout the forecast period. Computed tomography is expected to grow at the fastest rate during the forecast period due to rapid technological advancements, such as the development of hybrid imaging modalities and the integration of AI
• Based on end use, the hospital's segment dominated the market in 2020 due to the blooming healthcare service industry in developing countries. The ambulatory imaging centers segment is anticipated to witness the fastest growth during the forecast period
• North America captured the largest market share in 2020 due to the presence of a large number of industry players and the high frequency of new product launches

Access Press Release@ https://www.grandviewresearch.com/press-release/medical-imaging-systems

Medical Imaging Market Segmentation

Grand View Research has segmented the global diagnostic imaging market on the basis of product, end use, and region:

Medical Imaging Product Outlook (Revenue, USD Million, 2016 - 2028)

• X-ray
  • By Modality
    • Radiography
    • Fluoroscopy
    • Computed Radiography
  • By Mobility
    • Stationary
    • Mobile
  • By Product
    • Digital
    • Analog
  • By Application
    • General radiology
    • Dental
    • Breasts
    • Cardiology
    • Others
  • Ultrasound
    • By Product
      • 2D
      • 3D/4D
      • Doppler Ultrasound Devices
    • By Portability
      • Handheld
      • Cart/Trolley Based
    • By Application
      • Ob/Gyn
      • Cardiovascular
      • Musculoskeletal
      • Others
    • Computed Tomography
      • By Technology
        • High-end slice
        • Mid-end slice
        • Low-end slice
        • Cone beam
      • By Application
        • Oncology
        • Neurology
        • Cardiology
        • Vascular
        • Musculoskeletal
        • Others
      • Magnetic Resonance Imaging
        • By Architecture
          • Closed System
          • Open System
        • By Field Strength
          • Low Field Strength
          • Mid Field Strength
          • High Field Strength
        • By Application
          • Brain and neurological
          • Spine and musculoskeletal
          • Vascular
          • Abdomen
          • Cardiac
          • Breast
          • Other
        • Nuclear Imaging
          • By Product
            • SPECT
              • Hybrid SPECT
              • Standalone SPECT
            • Hybrid PET
            • Planar Scintigraphy
          • By Application
            • Oncology
            • Cardiology
            • Neurology
            • General Imaging

Medical Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Imaging Centers
• Others

Medical Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Turkey
  • Poland
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
  • Malaysia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iran

List of Key Players of Medical Imaging Market

• GE Healthcare
• Koninklijke Philips N.V.
• Siemens Healthineers
• CANON MEDICAL SYSTEMS CORPORATION
• Bruker
• Mediso Ltd.
• MILabs B.V.
• MR Solutions
• TriFoil Imaging
• PerkinElmer Inc.
• FUJIFILM VisualSonics Inc.
• Cubresa Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Abrasive Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 Abrasive Market Growth & Trends

The global abrasive market size is expected to reach USD 47.82 billion by 2028, expanding at a CAGR of 4.2% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to be driven by the rising growth in the metal fabrication industry on account of demand from the end-use sectors, such as automotive, aerospace, agriculture, and medical. Abrasives are tools used for shaping and providing a smooth finish to the surface of the product.

Based on product, the market has been segmented into coated, bonded, and others. The coated segment is anticipated to register the fastest growth rate over the forecast period on account of the increasing application of coated materials in metalworking, where products, such as sandpaper, are used for deburring. China held the largest share of the global market in 2020. The country leads in terms of production as well to cater to domestic demand, as it is also a huge manufacturing hub.

According to the USGS statistics, China was the largest producer of fused aluminum oxide and silicon carbide abrasives in 2019. Rising production in China has compelled other players in the value chain to expand their manufacturing capacities. For instance, in August 2020, Ahlstrom-Munksjö announced to make further investments in its Binzhou plant for producing abrasive backing paper. This investment aims at strengthening the company’s position as a leading producer for abrasive backings across the globe.

Despite the positive market outlook for the future, the market growth plummeted in 2020 on account of the Covid-19 pandemic. Several companies witnessed losses in 2020 as the manufacturing operations were suspended, which impacted both product manufacturing and consumption. For example, Grindwell Norton Ltd.’s abrasives division reported a drop in sales due to a decline in industrial activity and lockdown in the first quarter of 2020.

Request a free sample copy or view report summary: Abrasive Market Report

Abrasive Market Report Highlights

• The bonded products segment held the largest revenue share of over 43% in 2020 owing to increasing demand for these products from numerous industries including steel, automotive, cutting tools, food processing, and general engineering, among others
• The automotive & transportation application dominated the market with a share of more than 35% in 2020 and will retain the leading position throughout the forecast years
• The growth of this application segment can be attributed to the increasing production of Electric Vehicles (EVs) and the rising number of their charging stations
• Metal fabrication is anticipated to register the fastest CAGR during the forecast period. Metal fabricators look for high-performance abrasive discs and finishing materials to reduce the downtime of fabrication operations
• Asia Pacific is anticipated to register the fastest growth rate of 4.7% over the forecast period on account of rapid growth in the manufacturing sector in the developing economies, such as India, China, and South Korea

Access Press Release@ https://www.grandviewresearch.com/press-release/global-abrasives-market

Abrasive Market Segmentation

Grand View Research has segmented the global abrasive market on the basis of product, application, and region:

Abrasive Product Outlook (Revenue, USD Million, 2017 - 2028)

• Bonded
• Coated
• Others

Abrasive Application Outlook (Revenue, USD Million, 2017 - 2028)

• Automotive & Transportation
• Heavy Machinery
• Metal Fabrication
• Electrical & Electronics Equipment
• Others

Abrasive Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Abrasive Market

• 3M
• Asahi Diamond Industrial Co., Ltd.
• Bosch Ltd.
• CUMI
• Henkel AG & Co, KGaA
• Saint-Gobain

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.